| Denosumab in men receiving androgen-deprivation therapy for prostate cancer MR Smith, B Egerdie, NH Toriz, R Feldman, TLJ Tammela, F Saad, ... New England Journal of Medicine 361 (8), 745-755, 2009 | 1377 | 2009 |
| Gonadal steroids and body composition, strength, and sexual function in men JS Finkelstein, H Lee, SAM Burnett-Bowie, JC Pallais, EW Yu, LF Borges, ... New England Journal of Medicine 369 (11), 1011-1022, 2013 | 825 | 2013 |
| Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial BZ Leder, JN Tsai, AV Uihlein, PM Wallace, H Lee, RM Neer, ... The Lancet 386 (9999), 1147-1155, 2015 | 527 | 2015 |
| Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial JN Tsai, AV Uihlein, H Lee, R Kumbhani, E Siwila-Sackman, EA McKay, ... The Lancet 382 (9886), 50-56, 2013 | 505 | 2013 |
| Differential effects of androgens and estrogens on bone turnover in normal men BZ Leder, KM LeBlanc, DA Schoenfeld, R Eastell, JS Finkelstein The Journal of Clinical Endocrinology & Metabolism 88 (1), 204-210, 2003 | 325 | 2003 |
| Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial BZ Leder, JN Tsai, AV Uihlein, SAM Burnett-Bowie, Y Zhu, K Foley, H Lee, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), 1694-1700, 2014 | 308 | 2014 |
| Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis BZ Leder, LSL O'Dea, JR Zanchetta, P Kumar, K Banks, K McKay, ... The Journal of Clinical Endocrinology & Metabolism 100 (2), 697-706, 2015 | 250 | 2015 |
| Oral androstenedione administration and serum testosterone concentrations in young men BZ Leder, C Longcope, DH Catlin, B Ahrens, DA Schoenfeld, ... Jama 283 (6), 779-782, 2000 | 218 | 2000 |
| Sarcopenia during androgen-deprivation therapy for prostate cancer MR Smith, F Saad, B Egerdie, PR Sieber, TLJ Tammela, C Ke, BZ Leder, ... Journal of Clinical Oncology 30 (26), 3271, 2012 | 197 | 2012 |
| Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels BZ Leder, JL Rohrer, SD Rubin, J Gallo, C Longcope The Journal of Clinical Endocrinology & Metabolism 89 (3), 1174-1180, 2004 | 193 | 2004 |
| Gonadal steroid–dependent effects on bone turnover and bone mineral density in men JS Finkelstein, H Lee, BZ Leder, SAM Burnett-Bowie, DW Goldstein, ... The Journal of clinical investigation 126 (3), 1114-1125, 2016 | 182 | 2016 |
| Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite DH Catlin, BZ Leder, B Ahrens, B Starcevic, CK Hatton, GA Green, ... Jama 284 (20), 2618-2621, 2000 | 174 | 2000 |
| Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA‐HRpQCT study JN Tsai, AV Uihlein, SAM Burnett‐Bowie, RM Neer, Y Zhu, N Derrico, ... Journal of Bone and Mineral Research 30 (1), 39-45, 2015 | 164 | 2015 |
| Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men JS Finkelstein, BZ Leder, SAM Burnett, JJ Wyland, H Lee, AV de la Paz, ... The Journal of Clinical Endocrinology & Metabolism 91 (8), 2882-2887, 2006 | 158 | 2006 |
| Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels SAM Burnett-Bowie, EA McKay, H Lee, BZ Leder The Journal of Clinical Endocrinology & Metabolism 94 (12), 4785-4792, 2009 | 157 | 2009 |
| Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer MR Smith, F Saad, B Egerdie, M Szwedowski, TLJ Tammela, C Ke, ... The Journal of urology 182 (6), 2670-2676, 2009 | 135 | 2009 |
| Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis BZ Leder, RM Neer, JJ Wyland, HW Lee, SAM Burnett-Bowie, ... The Journal of Clinical Endocrinology & Metabolism 94 (8), 2915-2921, 2009 | 133 | 2009 |
| Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up) BZ Leder, JN Tsai, LA Jiang, H Lee Bone 98, 54-58, 2017 | 120 | 2017 |
| Effects of two years of teriparatide, denosumab, or both on bone microarchitecture and strength (DATA-HRpQCT study) JN Tsai, AV Uihlein, SM Burnett-Bowie, RM Neer, NP Derrico, H Lee, ... The Journal of Clinical Endocrinology & Metabolism 101 (5), 2023-2030, 2016 | 115 | 2016 |
| Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men AB Araujo, TG Travison, BZ Leder, JB McKinlay The Journal of Clinical Endocrinology & Metabolism 93 (6), 2135-2141, 2008 | 102 | 2008 |
